124 related articles for article (PubMed ID: 15726514)
1. Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer.
Grem JL
Semin Oncol; 2005 Feb; 32(1):120-7. PubMed ID: 15726514
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
3. [The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].
Laurent-Puig P; Lièvre A; Ducreux M; Loriot MA
Bull Cancer; 2008 Oct; 95(10):935-42. PubMed ID: 19004723
[TBL] [Abstract][Full Text] [Related]
4. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
Folprecht G; Köhne CH
Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
[TBL] [Abstract][Full Text] [Related]
5. The changing face of chemotherapy in colorectal cancer.
Waters J; Cunningham D
Br J Cancer; 2001 Jan; 84(1):1-7. PubMed ID: 11139304
[No Abstract] [Full Text] [Related]
6. Role of genomic markers in colorectal cancer treatment.
Allen WL; Johnston PG
J Clin Oncol; 2005 Jul; 23(20):4545-52. PubMed ID: 16002846
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism in colorectal cancer].
Hazama S; Oka M; Hinoda Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():42-6. PubMed ID: 14574853
[No Abstract] [Full Text] [Related]
8. Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer.
Zhu AX; Puchalski TA; Stanton VP; Ryan DP; Clark JW; Nesbitt S; Charlat O; Kelly P; Kreconus E; Chabner BA; Supko JG
Clin Colorectal Cancer; 2004 Feb; 3(4):225-34. PubMed ID: 15025795
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
10. The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.
Schmoll HJ
Semin Oncol; 2002 Oct; 29(5 Suppl 15):34-9. PubMed ID: 12422306
[TBL] [Abstract][Full Text] [Related]
11. Tailoring chemotherapy in advanced colorectal cancer.
Park DJ; Stoehlmacher J; Lenz HJ
Curr Opin Pharmacol; 2003 Aug; 3(4):378-85. PubMed ID: 12901946
[TBL] [Abstract][Full Text] [Related]
12. [Recent advance in chemotherapy for advanced colorectal cancer].
Aiba K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
[TBL] [Abstract][Full Text] [Related]
13. Expression of genes for 5-FU-metabolizing enzymes and response to irinotecan plus 5-FU-leucovorin in colorectal cancer.
Noda E; Maeda K; Inoue T; Nishihara T; Nishiguchi Y; Ohira M; Hirakawa K
Anticancer Res; 2006; 26(6C):4653-8. PubMed ID: 17214322
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
[TBL] [Abstract][Full Text] [Related]
15. [Molecular biology in clinical cancer research: the example of digestive cancers].
Lièvre A; Laurent-Puig P
Rev Epidemiol Sante Publique; 2005 Jun; 53(3):267-82. PubMed ID: 16227914
[TBL] [Abstract][Full Text] [Related]
16. Second-line therapy in colorectal cancer.
Berlin J
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):21-6. PubMed ID: 11204658
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.
Beaven AW; Goldberg RM
Oncology (Williston Park); 2006 Apr; 20(5):461-9; discussion 469-70, 473-5. PubMed ID: 16739745
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy for advanced colorectal cancer].
Munakata M; Sakata Y
Nihon Rinsho; 2011 Apr; 69 Suppl 3():30-6. PubMed ID: 22213927
[No Abstract] [Full Text] [Related]
19. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
Jensen SA; Vainer B; Sørensen JB
Int J Cancer; 2007 Feb; 120(3):694-701. PubMed ID: 17096352
[TBL] [Abstract][Full Text] [Related]
20. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
